Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artificial dura mater hydromorphone epidural sustained-release analgesia after lumbar fusion
ChiCTR2500096777Phase 4Not yet recruiting
- Sponsor
- Ganzhou People's Hospital
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in Herniated Lumbar Disk and spinal stenosis (2 arms), sponsored by Ganzhou People's Hospital. Primary endpoint: Visual Analog Scale (VAS) pain scores. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
Herniated Lumbar Diskspinal stenosis
Beyond the preview
Go deeper on ChiCTR2500096777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096777.